Our results have shown that the serum level of S100A8/9 was significantly higher in patients vis-a-vis healthy controls, and this over-expression was positively correlated with tumor size, which is in line with the reported higher gene expression of S100A8 and S100A9 in breast cancer (16). The gene discussed is S100A8; the disease is breast cancer.